Early Prevention of Preeclampsia Study



Status:Terminated
Conditions:Women's Studies
Therapuetic Areas:Reproductive
Healthy:No
Age Range:Any
Updated:7/1/2018
Start Date:March 2012
End Date:July 20, 2015

Use our guide to learn which trials are right for you!

Early Prediction and Aspirin for Prevention of Preeclampsia

This is a randomized controlled trial to estimate the efficacy of low dose aspirin for
preventing preeclampsia in women identified as high risk. The investigators hypothesize that
the risk of preeclampsia in women identified by a first trimester multiparameter predictive
model to be at high risk will be significantly reduced by initiating low dose aspirin early
in pregnancy.

This will be a randomized control trial to estimate the efficacy of low dose aspirin in
preventing preeclampsia in women identified in the first trimester to be at high risk. We
will also obtain maternal blood, cord blood and placenta specimen for basic science studies
to attempt to dissect biological mechanisms of aspirin effects. In addition we will conduct a
cost-benefit analysis to determine the cost effectiveness of screening and using aspirin
prophylaxis for screen positive women.

Rationale for Design: The randomized control trial is the 'gold standard' of research design.
Other designs such as case-control, retrospective cohort and prospective cohort are limited
by potential bias and confounding. Randomly assigning subjects to different interventions
minimizes selection bias. The random assignment also results in groups that are likely to be
similar with regards to important confounding variables. This minimizes confounding by both
measured and unmeasured factors. While random allocation does not guarantee the groups will
be identical, it does ensure that any differences between them are due to chance alone.
Finally, randomization produces groups that are random samples of the population. This
permits use of standard statistical tests that are based on probability theory.

Inclusion Criteria:

- Singleton pregnancy undergoing ultrasound examination at 9 0/7 - 14 6/7 weeks

- any one or more factors identified as high risk from the identified risk factors:
Chronic hypertension, prepregnancy diabetes mellitus, previous preeclampsia, obesity
(BMI >30), bilateral uterine artery notches preeclampsia risk score greater than 6,
low PAPP-A ( < 0.52 MoM)

Exclusion Criteria:

- Multiple gestations,

- fetal aneuploidy

- major fetal structural anomaly

- bleeding disorder

- allergy to aspirin

- women already on aspirin or heparin.
We found this trial at
1
site
Saint Louis, Missouri 63110
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials